Med-Tech Innovation August 21, 2024
Oliver Johnson

Thirona will continue to focus on pulmonary diseases and expanding within the interventional pulmonology space, while its RetCAD division will join forces with a global leader in eye care solutions.

Thirona, a global company specialised in advanced analysis of medical lung images with artificial intelligence (AI), has announced the divestment of Thirona Retina BV to Revenio Group Corporation’s subsidiary Icare Finland Oy.

After demonstrating impressive growth and ‘tremendous’ market potential according to the parent company, the Retina division of Thirona was spun off into Thirona Retina in 2023 to focus entirely on the eye disease market.

By joining forces with iCare, Thirona Retina says it is poised to enhance patient outcomes and drive innovation in eye care. Leveraging iCare’s...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Medical Devices, Mergers & Acquisitions / JV, Trends
UN warns of military brain control
Only 20% of AI devices for children used pediatric data to train: 3 notes
Medtech firms have cut thousands of jobs this year. Will layoffs continue in 2025?
Proton therapy market in the US projected to reach $2.67 billion by 2033
How Trump’s second term will affect the medtech industry

Share This Article